Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1. [electronic resource]
Producer: 20160926Description: 1169-86 p. digitalISSN:- 1750-7448
- Animals
- Antigens, CD -- metabolism
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- B7-H1 Antigen -- antagonists & inhibitors
- CTLA-4 Antigen -- immunology
- Clinical Trials as Topic
- Humans
- Immunotherapy
- Molecular Targeted Therapy
- Neoplasms -- immunology
- Programmed Cell Death 1 Receptor -- immunology
- Tumor Escape -- drug effects
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Lymphocyte Activation Gene 3 Protein
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.